Skp2 Overexpression Is Associated with Loss of BRCA2 Protein in Human Prostate Cancer
- 31 May 2011
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 178 (5) , 2367-2376
- https://doi.org/10.1016/j.ajpath.2011.01.050
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- BRCA2 acts as a RAD51 loader to facilitate telomere replication and cappingNature Structural & Molecular Biology, 2010
- Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescenceNature, 2010
- New Developments in the Medical Management of Prostate CancerMayo Clinic Proceedings, 2010
- Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKBNature Cell Biology, 2009
- Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destructionNature Cell Biology, 2009
- Rapid progression of prostate cancer in men with a BRCA2 mutationBritish Journal of Cancer, 2008
- Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotypeBritish Journal of Cancer, 2008
- Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancerBritish Journal of Cancer, 2007
- Hallmarks of 'BRCAness' in sporadic cancersNature Reviews Cancer, 2004
- BRCA2 Is Ubiquitinated In Vivo and Interacts with USP11, a Deubiquitinating Enzyme That Exhibits Prosurvival Function in the Cellular Response to DNA DamageMolecular and Cellular Biology, 2004